Risk of reactivation of Hepatitis B with corticosteroids
In a retrospective territory-wide study from Hong Kong patients
who were negative for Hepatitis B surface antigen (HBsAg)
who received corticosteroids were evaluated for the risk
of seroreversion.
EACS Guidelines
Magazine